Residents of Sydney’s South-West will soon have access to a 2,713 sqm purpose-built $50 million integrated cancer care centre in Campbelltown, with the structure of the centre now complete.
Due to open in mid-2024, the cancer care centre will feature medical and radiation oncology services, medical imaging, pathology, consultation suites, a clinical trials and research unit, and access to allied health services.
The new integrated cancer care centre is the result of a partnership between Campbelltown City Council, Northwest Healthcare Properties, GenesisCare, and Erilyan.
Lumus Imaging has been confirmed as the medical imaging service provider, while Laverty Pathology has been confirmed as the pathology service provider. Lumus Imaging and Laverty Pathology are part of the ASX-listed healthcare group Healius Limited.
The cancer care centre is the first stage 1 of a new, state-of-the-art healthcare precinct being developed by Northwest Healthcare Properties that will deliver other healthcare services, including day surgery, mental health, diagnostics, specialist consulting rooms, and primary and allied care.
Campbelltown mayor Dr George Greiss said, “This is an exciting milestone for a project that will deliver a range of important healthcare services to our growing community.
“Working together with our excellent public facilities, this project will enhance and expand the capacity of cancer treatment and research across the region.”
“We are excited to be part of this dedicated and important healthcare hub, offering personalised, evidence-based care to local cancer patients," said GenesisCare’s general manager Michael Davis.
“The centre will offer modern radiation and medical oncology treatments and technology, with access to our global network of clinical trials, all in a sustainably built environment. We understand that being treated for cancer can be a stressful time, and knowing that care is available close to home will hopefully be a relief for local patients.”